Mitochondrial DNA Haplogroups and Breast Cancer Risk Factors in the Avon Longitudinal Study of Parents and Children (ALSPAC)

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2018
Editora
MDPI
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
RILEY, Vivienne
ERZURUMLUOGLU, A. Mesut
RODRIGUEZ, Santiago
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
GENES, v.9, n.8, article ID 395, 31p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The relationship between mitochondrial DNA (mtDNA) and breast cancer has been frequently examined, particularly in European populations. However, studies reporting associations between mtDNA haplogroups and breast cancer risk have had a few shortcomings including small sample sizes, failure to account for population stratification and performing inadequate statistical tests. In this study we investigated the association of mtDNA haplogroups of European origin with several breast cancer risk factors in mothers and children of the Avon Longitudinal Study of Parents and Children (ALSPAC), a birth cohort that enrolled over 14,000 pregnant women in the Southwest region of the UK. Risk factor data were obtained from questionnaires, clinic visits and blood measurements. Information on over 40 independent breast cancer risk factor-related variables was available for up to 7781 mothers and children with mtDNA haplogroup data in ALSPAC. Linear and logistic regression models adjusted for age, sex and population stratification principal components were evaluated. After correction for multiple testing we found no evidence of association of European mtDNA haplogroups with any of the breast cancer risk factors analysed. Mitochondrial DNA haplogroups are unlikely to underlie susceptibility to breast cancer that occurs via the risk factors examined in this study of a population of European ancestry.
Palavras-chave
mitochondrial DNA, haplogroups, breast cancer, risk factors, ALSPAC, Europeans
Referências
  1. Bandelt HJ, 2008, INT J ANDROL, V31, P450, DOI 10.1111/j.1365-2605.2007.00786.x
  2. Blein S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0567-2
  3. Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064
  4. Cancer Research UK, BREAST CANC
  5. Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876
  6. Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
  7. Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
  8. de Bruijn KMJ, 2013, BRIT J SURG, V100, P1421, DOI 10.1002/bjs.9229
  9. Ebner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135622
  10. Emery LS, 2015, AM J HUM GENET, V96, P183, DOI 10.1016/j.ajhg.2014.12.015
  11. Erzurumluoglu AM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010045
  12. Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276
  13. Fachal L, 2014, J HUM GENET, V59, P411, DOI 10.1038/jhg.2014.46
  14. Fraenkel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070980
  15. Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066
  16. Grant SFA, 2012, INT J OBESITY, V36, P80, DOI 10.1038/ijo.2011.206
  17. Grzybowska-Szatkowska L, 2012, MOL MED REP, V6, P923, DOI 10.3892/mmr.2012.1027
  18. Gunnell D, 2004, J CLIN ENDOCR METAB, V89, P213, DOI 10.1210/jc.2003-030507
  19. Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb
  20. HOLM S, 1979, SCAND J STAT, V6, P65
  21. Howe LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10871-4
  22. Jeffreys M, 2011, CANCER CAUSE CONTROL, V22, P945, DOI 10.1007/s10552-011-9767-y
  23. Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016
  24. Kirkwood B.R., 2007, MED STAT
  25. Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
  26. Knoll N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094882
  27. Maisonet M, 2015, ENVIRON HEALTH PERSP, V123, P1325, DOI 10.1289/ehp.1408847
  28. Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
  29. Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
  30. Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385
  31. Nardelli C, 2013, BIOMED RES INT, DOI 10.1155/2013/631082
  32. Ong K, 2000, J CLIN ENDOCR METAB, V85, P4266, DOI 10.1210/jc.85.11.4266
  33. Pardo-Seco J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073567
  34. Pereira L, 2005, INT J ANDROL, V28, P241, DOI 10.1111/j.1365-2605.2005.00539.x
  35. Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254
  36. Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930
  37. Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401
  38. Rohan TE, 2010, J ONCOL, DOI 10.1155/2010/604304
  39. Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239
  40. Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062
  41. Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
  42. Salas A, 2015, J GENET GENOMICS, V42, P169, DOI 10.1016/j.jgg.2015.03.002
  43. Salas A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-659
  44. Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347
  45. Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
  46. Sequeira ME, 2017, BRIT J PSYCHIAT, V210, P39, DOI 10.1192/bjp.bp.115.168617
  47. Shaheen SO, 2007, ALLERGY, V62, P25, DOI 10.1111/j.1398-9995.2006.01240.x
  48. Terry MB, 2004, JAMA-J AM MED ASSOC, V291, P2433, DOI 10.1001/jama.291.20.2433
  49. Tommasi S, 2014, INT J ONCOL, V44, P1691, DOI 10.3892/ijo.2014.2324
  50. van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
  51. Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283
  52. World Cancer Research Fund/American Institute for Cancer Research, 2017, DIET NUTR PHYS ACT B
  53. Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595